Apr 26, 2023 | Anniversaries, Announcements, Benchmarks, Hospital Service Association, MedBen PreceDent, MedBen Rx, Medical Benefits Administrators, Medical Benefits Mutual, VisionPlus
May 8, 2023 marks MedBen’s 85th anniversary of serving the health benefit needs of employers across the country. As such, it’s an opportune time to reflect, while also looking forward. MedBen’s growth over the decades has coincided with the evolution...
Apr 25, 2023 | Coinsurance, Copayments, Deductibles, Explanation of benefits (EOB), ID Card, MedBen Access, MedBen Basics, MedBen Rx, Mobile App, Online Services, Plan members, Prescription Portal
Health benefits management can be a complicated business, but that doesn’t mean it has to be. To help make things a bit more clear cut, MedBen offers dozens of MedBen Basic handouts on a variety of topics. While many of our Basics are directed at plan...
Apr 14, 2023 | Announcements, Client Report, Direct-to-Employer Contracting, Kurt Harden, MedBen Rx, Member engagement, Supreme Court
In the upcoming 2023 MedBen Client Report, we’ll be looking at some of the issues that affected our clients last year, and the ways we worked with them to find successful solutions to preserve or improve their benefits. “With health care inflation expected...
Mar 21, 2023 | Brand Name Drugs, Diabetes, Drug costs, Generic Drugs, Insulin, Kurt Harden, MedBen Rx, MedBen University, Pharmacy Benefits Manager (PBM), Prescription
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing drugmakers Novo Nordisk...
Mar 6, 2023 | Access solutions, Cost Savings, MedBen Rx, Medicare, Research, Rx Costs, Savings, Specialty Drugs
Employers pay up to 30 times as much for specialty drugs than Medicare does, new research finds. According to the JAMA Health Forum, for the 10 most commonly used specialty drugs, employer-sponsored insurance (ESI) plans paid prices up to 3,350% higher than Medicare....
Feb 21, 2023 | Comparative Effectiveness, Drug advertising, MedBen Rx, Research, TruDataRx
Drug companies spend $6 billion per year on direct-to-consumer ads with the goal of getting patients to ask their doctors to prescribe drugs that, in many instances, cost substantially more but are less effective than their current medications. And with no comparative...
